Related Experiment Video
Updated: Jul 2, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Recurrent Periprosthetic Joint Infections: Diagnosis, Management, and Outcomes
Christopher F Deans1, Beau J Kildow1, Kevin L Garvin1
1Department of Orthopaedic Surgery and Rehabilitation, University of Nebraska Medical Center, 985640 Nebraska Medical Center, Omaha, NE 68198, USA.
Abstract:
Periprosthetic joint infection (PJI) remains one of the most common complications after total joint arthroplasty. It is challenging to manage, associated with significant morbidity and mortality, and is a financial burden on the health care system. Failure of 2-stage management for chronic PJI is not uncommon. Repeat infections are oftentimes polymicrobial, multiple drug-resistant microorganisms, or new organisms. Optimizing the success of index 2-stage revision is the greatest prevention against failure of any subsequent management options and requires a robust team-based approach.
Insights
Periprosthetic joint infection (PJI) is a common complication after joint replacement surgery. Optimizing the initial 2-stage revision surgery is crucial to prevent repeat infections and improve patient outcomes.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Biomedical Engineering
Background:
- Periprosthetic joint infection (PJI) is a significant complication following total joint arthroplasty.
- PJI presents substantial challenges in management, leading to increased morbidity, mortality, and healthcare costs.
- Chronic PJI cases often exhibit treatment failures, with repeat infections involving polymicrobial or multidrug-resistant organisms.
Purpose of the Study:
- To emphasize the critical importance of optimizing the initial 2-stage revision surgery for periprosthetic joint infection.
- To highlight the necessity of a comprehensive, team-based strategy in managing chronic PJI.
- To underscore the role of successful index procedures in preventing subsequent management failures.
Main Methods:
- Review of clinical literature and treatment guidelines for periprosthetic joint infection.
- Analysis of factors contributing to the failure of 2-stage revision protocols.
- Emphasis on multidisciplinary team collaboration in surgical site infection management.
Main Results:
- Failure rates in 2-stage management for chronic PJI are notably high.
- Recurrent infections frequently involve complex microbial profiles, including resistant strains.
- Successful initial 2-stage revision surgery is paramount for long-term outcomes.
Conclusions:
- Optimizing the success of the index 2-stage revision is the most effective strategy to prevent future PJI recurrence.
- A robust, team-based approach is essential for successful management of chronic PJI.
- Addressing challenges in initial treatment can mitigate the significant burden of repeat infections.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Pancreatitis II: Collaborative Care
Assessment:

